Premier Health Enters Into Binding Agreement to Acquire Leading Ontario Agency Canadian Health Care Agency

Premier Health Enters Into Binding Agreement to Acquire Leading Ontario Agency Canadian Health Care Agency

Premier Health of America Inc. (TSXV: PHA ) (" Premier Health " or the " Corporation "), a leading Canadian Healthtech company, is pleased to announce that it has entered this day into a share purchase agreement (the " SPA ") to acquire, through a newly created wholly owned federally incorporated subsidiary, 13822214 Canada (" CanCo "), 100% of the outstanding shares of Umana Holdings Inc. (" Umana ") and its wholly-owned subsidiary Canadian Health Care Agency, (" CHCA ") for a total consideration comprised between C$10.5M to C$14.5M (the " Purchase Price "), payable in cash, depending on the achievement of performance objectives (the " Transaction "), minus indebtedness, as more fully detailed below. As a result of the Transaction and a corporate reorganization, CHCA will become a wholly owned subsidiary of the Corporation. The Corporation will continue the business of CHCA which consists in providing specialized nursing services.

"The acquisition of CHCA starts our expansion outside of the province of Quebec and consolidates our market position in Canada's northern regions" Said Martin Legault, CEO of Premier Health. " In addition, the Cambridge based agency provides us with a good management infrastructure in Ontario that will serve as a base to continue our expansion in this province. This is a strategy we are expecting to follow in other provinces as well."

CHCA is the primary provider to Indigenous Services Canada ("ISC") for nursing services to remote and semi-remote Indigenous communities in both Ontario and Alberta. In addition, CHCA provides nurses services as a backup provider to ISC for these communities in Manitoba. CHCA is based in Cambridge, Ontario, and was founded in 2001 in response to severe staffing shortages in Canada's northern regions. CHCA started its operations in Northern Ontario and quickly expanded its activities to providing services in Nunavut and Northern Manitoba. CHCA currently has over 200 active and specially trained Registered Nurses and Nurse Practitioners in its organization. For the fiscal year ending January 31, 2022, CHCA generated revenues of C$34.5M (of which an estimated C$10.3M were Covid related non-recurring isolation revenues), an EBITDA of C$6.4M (of which an estimated C$3.0M was Covid related non-recurring isolation EBITDA) and a net income of C$4.6M (of which an estimated C$3.0M was Covid related non-recurring isolation net income).

"Our objective is to continue building on our foundation of offering superior care and services to our communities" Said Sharon Umana, CEO of CHCA "Teaming up with Premier Health is a natural fit for us that will allow us to capitalize on the strengths of our nurses and nurse practitioners into even more opportunities to provide care."

Transaction Details

CanCo has entered into the SPA with the shareholders of Umana to acquire all of the issued and outstanding shares of CHCA on a cash free and debt free basis for a total cash consideration of up to C$14.5M million, comprised of a C$10.5M cash payment less indebtedness at closing of the Transaction (the " Closing "), a C$Nil to C$3M deferred cash consideration payable over two years subject to the achievement of EBITDA objectives, and a C$Nil to C$1M deferred cash consideration payable one year after Closing, linked to isolation revenues if any. The Transaction is subject to working capital adjustments to be completed within 90 days following the Closing of the Transaction. The Transaction is subject to customary conditions precedent, including without limitation, receipt of any required approval and completion of satisfactory due diligence, and is expected to close on or about April 19, 2022. The Transaction is an arm's-length transaction, and Acumen Capital Partners acted as adviser for the Transaction.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb software platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services.

Non-GAAP Measures

Earnings before interest, taxes, depreciation, and amortization (" EBITDA "), is calculated as the net profit (loss), before acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation and stock-based compensation), interest expense, net of interest income and income tax expense.

For Further Information Please Contact :

Mr. Jean-Robert Pronovost
Vice-President, Corporate Development
Premier Health of America Inc.
jrpronovost@premierhealth.ca / 1 800 231 9916

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PHA:CA
The Conversation (0)
Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announced today that the TSX Venture Exchange (" TSXV ") has accepted the Corporation's application for its normal course issuer bid (the " NCIB ") for a portion of its outstanding common shares (" Common Shares ") as appropriate opportunities arise from time to time. The Corporation's NCIB will be made in accordance with the requirements of the TSXV and applicable securities laws.

Pursuant to the NCIB, Premier Health may repurchase up to a maximum of 1,428,571 Common Shares representing approximately a value of $500,000 at the current market price and 7% of its public float, where the aggregate public float as at November 14, 2022, was 19,664,860 Common Shares. Purchases under the NCIB may be made through the facilities of the TSXV, based on the prevailing market price at the time of acquisition. The NCIB will be funded using existing cash resources and any Common Shares purchased under the NCIB will be cancelled.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Announces CFO Transition

Premier Health Announces CFO Transition

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, today announced that it is proceeding with a transition of the CFO functions and appoints Simon Belval as Interim Chief Financial Officer, effective immediately.

Simon Belval is a seasoned professional that has demonstrated strong abilities and leadership in finance and accounting functions including IFRS reporting, tax planning, financing, and risk management in different environments. He has held several leadership roles in the technology and fintech sectors and has developed over the years an expertise in managing strategic initiatives and special situations. He started his career as an external auditor and later acted as senior financial analyst for major organizations in Eastern Canada. Simon is a member of the Ordre des comptables professionnels agrées du Québec (CPA) and a Chartered Financial Analyst (CFA).

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Reports FY2022 Third Quarter Results

Premier Health Reports FY2022 Third Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its third quarter ended June 30, 2022.

Summary

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health Reports FY2022 Second Quarter Results

Premier Health Reports FY2022 Second Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022.

Summary

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Premier Health of America

Premier Health Announces the Appointment of Giovanni Garay as Ontario General Manager

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announces the appointment of Giovanni Garay as Ontario General Manager, effective immediately.

"We are very excited to have Giovanni join Premier Health. His hiring follows our recent acquisition in Ontario, and he will be an important member of the Corporation's senior leadership team," said Martin Legault, Chief Executive Officer. "Giovanni's experience with large organisations will benefit Premier Health as we continue to expand our footprint in the province." he added.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Sempra Appoints Jennifer M. Kirk to Board of Directors

Sempra (NYSE: SRE) (BMV: SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20 2024. Kirk is currently the global controller and chief accounting officer of Medtronic plc (NYSE: MDT) and has deep executive experience in finance, accounting and capital market activities, including more than 20 years in the energy industry.

Jennifer M. Kirk

"Bringing new perspectives into the boardroom is a critical component of our effort to support the company's mission to build North America's premier energy infrastructure company," said Jeffrey W. Martin , Sempra chairman and CEO. "Our board of directors embody a diverse set of skills, experiences and viewpoints that help guide Sempra's corporate strategy and overall business success. Jennifer's strong accounting and finance experience, coupled with her understanding of the energy business, will be a great complement to the board as we advance our corporate strategy and oversee financial discipline, risk management and ethical practices."

Before joining Medtronic, Kirk, 49, worked at Occidental Petroleum Corporation for more than two decades, serving in roles of increasing responsibility, including senior vice president of integration and value capture, and vice president, controller and principal accounting officer.

Kirk serves on the board of directors of Republic Services, where she is chair of the audit committee. She holds a bachelor's degree in economics from UC Santa Barbara and a master's degree in business administration from California State University, Bakersfield .

With the appointment of Kirk, Sempra will have 10 directors with three having been newly elected over the past five years, reflecting the company's commitment to periodic board refreshment to ensure fresh and diverse perspectives are present in the boardroom. Kirk will serve on the board's audit committee and the safety, sustainability and technology committee.

About Sempra
Sempra (NYSE: SRE) is a leading North American energy infrastructure company focused on delivering energy to nearly 40 million consumers. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving the energy resilience of some of the world's most significant economic markets, including California , Texas , Mexico and global energy markets. The company is recognized as a leader in sustainable business practices and for its high-performance culture focused on safety and operational excellence, as demonstrated by Sempra's inclusion in the Dow Jones Sustainability Index North America and in The Wall Street Journal's Best Managed Companies. More information about Sempra is available at sempra.com and on social media @Sempra .

Sempra Logo (PRNewsfoto/Sempra)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/sempra-appoints-jennifer-m-kirk-to-board-of-directors-302177421.html

SOURCE Sempra

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Cardiex Limited

Cardiex Sales and Operations Update

On behalf of Cardiex (ASX:CDX) (the “Company”), I’m pleased to provide the following updates on recent progress across our business units.

Keep reading...Show less
Cardiex Limited

Options Prospectus

Cardiex Limited (ASX:CDX) (Cardiex, the Company) is pleased to share its Options Prospectus.
Keep reading...Show less

Medtronic LABS Documentary: Better Health for Everyone, Everywhere

Reaching more communities with healthcare technology through Medtronic LABS

Jane Muthoni faced frequent illness during her childhood before she was diagnosed with diabetes. Knowing that over half the world's population can't access essential health services - she now travels around Africa to help others live healthier lives through her work with Medtronic LABS

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cleo Diagnostics CEO Richard Allman.

Cleo Diagnostics Revolutionises Ovarian Cancer Screening with Early Detection

Australia-based Cleo Diagnostics (ASX:COV) is poised to offer a groundbreaking solution for ovarian cancer screening through innovative blood tests that promise accurate and early cancer detection.

In a recent interview, Cleo Diagnostics CEO Dr. Richard Allman discussed the company's path to revolutionise ovarian cancer screening.

The insidious nature of ovarian cancer, which often goes undetected until it's too late, has necessitated a fresh approach to early diagnosis. Allman explained that the prototype test from Cleo Diagnostics exhibits a 95 percent sensitivity and specificity rate, and has an accuracy of above 80 percent for detecting early stage cancer. In comparison, the accuracy of the existing biomarker CA 125 is about 50 percent, he said.

Keep reading...Show less

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

The Thermo Scientific™ Stellar™ mass spectrometer combines speed and sensitivity to advance precision medicine

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Stellar™ mass spectrometer (MS), a new solution that combines fast throughput, high sensitivity, and ease of use to allow researchers to advance their translational omics research and make breakthrough discoveries more efficiently.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×